KPTI vs VICI · rev $68.5M vs P/E 9.3, rev $2.08B
Karyopharm Therapeutics Inc (KPTI) versus VICI Properties Inc (VICI) — a side-by-side from cached financials, not a winner call.
Karyopharm Therapeutics Inc (KPTI) is a biotechnology company listed on US.
VICI Properties Inc (VICI) is a reit - diversified company listed on NYSE.
Latest reported KPTI revenue for 2026-06-30 was $68.5M. Net income was -$89.4M. Revenue was up 95.3% from 2026-03-31 to 2026-06-30. KPTI currently screens at market cap $205.6M.
Latest reported VICI revenue for 2026-06-30 was $2.08B. Net income was $1.40B. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
KPTI currently screens at market cap $205.6M. VICI currently screens at market cap $29.32B and trailing P/E 9.3.
Not investment advice. Open the KPTI and VICI stock pages for the full models.
Not investment advice.